Abiopharma

FDA approve LABETALOL HYDROCHLORIDE

FDA approve GLATIRAMER ACETATE

FDA approve DAPTOMYCIN

FDA approve TACROLIMUS

ベイジーン、2025年第1四半期の財務結果および事業最新情報を発表

Filing of Form 10-Q

Imfinzi improved DFS in early bladder cancer

Request for Lifting of Trading Halt: Request for Lifting of Trading Halt

Lonza Q1 2025 Qualitative Update: Strong Performance Across All Businesses in Line with Expectations for Full-Year 2025

General Announcement: Q1 Qualitative Update: Strong Performance Across All Businesses in Line with Expectations for FY 25

Request for Trading Halt: Request for Trading Halt

LIVEPERSON (LPSN) was added to the list of traded instruments on TASE exchange

GERN Investors Have Opportunity to Join Geron Corporation Fraud Investigation with the Schall Law Firm

Ceasing to be a substantial holder

FARO TECHNOLOGIES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of FARO Technologies, Inc. - FARO